S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
CVE:ICO

iCo Therapeutics Stock Forecast, Price & News

C$0.10
0.00 (0.00 %)
(As of 03/19/2021)
Add
Compare
Today's Range
C$0.10
C$0.11
50-Day Range
C$0.11
C$0.11
52-Week Range
C$0.02
C$0.16
Volume1.31 million shs
Average Volume3.16 million shs
Market CapitalizationC$951,825.00
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive ICO News and Ratings via Email

Sign-up to receive the latest news and ratings for iCo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.


About iCo Therapeutics

iCo Therapeutics Inc., a biotechnology company, focuses on the identification, development, and commercialization of drug candidates to treat ocular and infectious diseases. Its in-licensed drug candidates include iCo-008, a human monoclonal antibody, which is in Phase II clinical trial to treat ulcerative colitis and bullous pemphigoid; and Oral AmpB Delivery System, an oral formulation of Amphotericin B that is in Phase 1b clinical trial for the treatment of systemic fungal and parasitic infections. The company was incorporated in 2005 and is headquartered in Vancouver, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A
Cash Flow
C$0.01 per share
Book Value
C$0.00 per share

Profitability

Debt

Price-To-Earnings

Miscellaneous

Market Cap
C$951,825.00
Next Earnings Date
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

0.85 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












iCo Therapeutics (CVE:ICO) Frequently Asked Questions

What stocks does MarketBeat like better than iCo Therapeutics?

Wall Street analysts have given iCo Therapeutics a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but iCo Therapeutics wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has iCo Therapeutics' stock price been impacted by Coronavirus?

iCo Therapeutics' stock was trading at C$0.05 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, ICO shares have increased by 133.3% and is now trading at C$0.11.
View which stocks have been most impacted by COVID-19
.

Who are iCo Therapeutics' key executives?

iCo Therapeutics' management team includes the following people:
  • Mr. William Wasyl Jarosz, Chairman & CEO (Age 65)
  • Mr. Michael Liggett B.Sc., C.A., C.P.A., CPA, CA, Bsc. Pharm., CFO, Corp. Sec. & Director (Age 61, Pay $42.45k)
  • Dr. Peter Hnik, Chief Medical Officer & Director (Age 65)

What other stocks do shareholders of iCo Therapeutics own?

What is iCo Therapeutics' stock symbol?

iCo Therapeutics trades on the Canadian Venture Exchange (CVE) under the ticker symbol "ICO."

How do I buy shares of iCo Therapeutics?

Shares of ICO and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is iCo Therapeutics' stock price today?

One share of ICO stock can currently be purchased for approximately C$0.11.

How much money does iCo Therapeutics make?

iCo Therapeutics has a market capitalization of C$951,825.00.

What is iCo Therapeutics' official website?

The official website for iCo Therapeutics is www.icotherapeutics.com.

Where are iCo Therapeutics' headquarters?

iCo Therapeutics is headquartered at 760-777 Hornby St, VANCOUVER, BC V6Z 1S4, Canada.

How can I contact iCo Therapeutics?

iCo Therapeutics' mailing address is 760-777 Hornby St, VANCOUVER, BC V6Z 1S4, Canada. The company can be reached via phone at +1-604-6029414.


This page was last updated on 10/25/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.